Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 468277017 | Azelastine hydrochloride 0.1% nasal spray | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 721088019 | Azelastine hydrochloride 0.1% nasal spray (substance) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1192371010 | Azelastine hydrochloride 0.1% nasal spray (product) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 2536285014 | Azelastine hydrochloride 1% spray | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 2695297016 | Azelastine hydrochloride 137 mcg nasal spray | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3695837011 | Product containing precisely azelastine hydrochloride 140 microgram/actuation conventional release nasal spray | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3695838018 | Azelastine hydrochloride 140 microgram/actuation nasal spray | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3695839014 | Product containing precisely azelastine hydrochloride 140 microgram/actuation conventional release nasal spray (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3759743019 | Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 46758701000001114 | Azelastine 140micrograms/actuation nasal spray | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 58720201000001119 | Azelastine 140micrograms/dose nasal spray | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Is a | Azelastine hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Is a | Product containing azelastine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Is a | Nasal anti-inflammatory preparation | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has active ingredient | Azelastine hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Is a | Product containing azelastine in nasal dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has manufactured dose form | Nasal dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has manufactured dose form | Conventional release nasal spray | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has unit of presentation | Actuation | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has presentation strength denominator unit | Actuation | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has basis of strength substance | Azelastine hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has precise active ingredient | Azelastine hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has presentation strength numerator value | 140 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Is a | Product containing only azelastine in nasal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has active ingredient | Azelastine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has manufactured dose form | Conventional release nasal spray | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has unit of presentation | Actuation | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | solutionspray.nasal ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Nasal route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has manufactured dose form | Nasal dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has manufactured dose form | Spray | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Is a | Azelastine | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has manufactured dose form | Conventional release nasal spray | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has unit of presentation | Actuation | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has manufactured dose form | Conventional release nasal spray | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has unit of presentation | Actuation | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has manufactured dose form | Spray dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has manufactured dose form | Spray dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has specific active ingredient | Azelastine hydrochloride | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has dispensed dose form | Spray dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Has manufactured dose form | Spray dose form | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Azelastine hydrochloride 0.1% nasal spray - product | Is a | False | Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) | Is a | True | Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Rhinolast 140micrograms/actuation nasal spray (PI) (Waymade Ltd) | Is a | True | Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Aller-Eze 140micrograms/actuation nasal spray (Novartis Consumer Health UK Ltd) | Is a | True | Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Azelastine 140micrograms/actuation nasal spray 10 ml | Is pack of | False | Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Azelastine 140micrograms/actuation nasal spray 20 ml | Is pack of | False | Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Azelastine 140micrograms/actuation nasal spray 5 ml | Is pack of | False | Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Azelastine 140micrograms/actuation nasal spray 22 ml | Is pack of | False | Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Rhinolast 140micrograms/actuation nasal spray (PI) (Dowelhurst Ltd) | Is a | True | Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd) | Is a | True | Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Rhinolast 140micrograms/actuation nasal spray (Sigma Pharmaceuticals Plc) | Is a | True | Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Azelastine 140micrograms/actuation nasal spray 22 ml | Has VMP | True | Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Azelastine 140micrograms/actuation nasal spray 10 ml | Has VMP | True | Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Azelastine 140micrograms/actuation nasal spray 20 ml | Has VMP | True | Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Azelastine 140micrograms/actuation nasal spray 5 ml | Has VMP | True | Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Rhinolast 140micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) | Is a | True | Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Rhinolast 140micrograms/dose nasal spray (Lexon (UK) Ltd) | Is a | True | Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR